NCT00365014

Brief Summary

The purpose of this study is to identify and characterize blood diseases presenting at Shanghai hospitals and to compare them with respect to clinical presentation, phenotype, molecular characteristics, benzene or other exposures and genetic susceptibility.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,757

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2003

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2003

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

August 14, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 16, 2006

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2009

Completed
Last Updated

July 23, 2013

Status Verified

July 1, 2013

Enrollment Period

6.3 years

First QC Date

August 14, 2006

Last Update Submit

July 19, 2013

Conditions

Hematologic Diseases

Keywords

aplastic anemiamyelodysplastic syndromescytopeniasacute myeloid leukemiamyelodysplastic/myeloproliferative diseasesbenzene poisoning

Outcome Measures

Primary Outcomes (1)

  • blood diseases presenting at Shanghai hospitals

    characterization of people with blood diseases presenting at Shanghai hospitals

    hospital stay

Study Arms (1)

Blood disease patients

People with blood diseases presenting at Shanghai hospitals

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with blood diseases

You may qualify if:

  • Men and women 18 years or older Diagnosis of hematologic abnormality

You may not qualify if:

  • Children Non hematologic diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Joint Sino-US Clinical and Molecular Laboratory (JCML)

Shanghai, 200032, China

Location

MeSH Terms

Conditions

Hematologic DiseasesAnemia, AplasticMyelodysplastic SyndromesCytopeniaLeukemia, Myeloid, AcuteMyelodysplastic-Myeloproliferative Diseases

Condition Hierarchy (Ancestors)

Hemic and Lymphatic DiseasesAnemiaBone Marrow Failure DisordersBone Marrow DiseasesLeukemia, MyeloidLeukemiaNeoplasms by Histologic TypeNeoplasms

Study Officials

  • Richard D Irons, PhD

    University of Colorado at Denver and Health Sciences Ctr.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 14, 2006

First Posted

August 16, 2006

Study Start

August 1, 2003

Primary Completion

December 1, 2009

Study Completion

December 1, 2009

Last Updated

July 23, 2013

Record last verified: 2013-07

Locations

CN(1)